PTThe Paper Trail Project
Sourced institutional rolesLDA lobbying records

STEPHEN WEYLER

STEPHEN WEYLER appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.

Data updated Aug 31, 2026

Source-backed chronology

Career Timeline

Dates not reported

Health and Labor Fellow, U.S. House of Representatives, Committee on Education & Labor (2019)

Federal government

Inspect source ↗

Documented career transitions

Revolving Door

Congress → Lobbying

Federal governmentHealth and Labor Fellow, U.S. House of Representatives, Committee on Education & Labor (2019)Palantir TechnologiesRegistered lobbyist

Federal LDA filings

Lobbying Activity

PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2023

Registrant: INVARIANT LLC · Health Issues

Support funding for the Food and Drug Administration 21 Forward Program, National Institutes of Health N3C Program, and Centers for Disease Control and Prevention, the Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act. Monitor Pandemic All Hazards Preparedness Act and related legislation, highlighting ongoing work with ASPR.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2023

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2024

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All- Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Support funding for ASPR Supply Chain Control Tower.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2024

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, CDC Data Modernization Initiative, and ASPR Supply Chain Control Tower. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Highlight how Palantir's technology is being used by hospitals and health systems.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2025

Registrant: INVARIANT LLC · Taxation/Internal Revenue Code

Discuss how commercial technology can be leveraged by IRS to fight fraud and improve customer experience.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2022

Registrant: INVARIANT LLC · Homeland Security

Support the ongoing deployment of commercial data software solutions related to the USCG, FAA, and ICE-HSI.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2022

Registrant: INVARIANT LLC · Health Issues

Discuss the use of Palantir's commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support data sharing models at the National Institutes of Health; support funding for the Food and Drug Administration's 21Forward initiative; monitor Senate pandemic preparedness legislation including S.3799, PREVENT Pandemics Act.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2022

Registrant: INVARIANT LLC · Homeland Security

Support the ongoing deployment of commercial data software solutions related to the USCG and ICE-HSI.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2022

Registrant: INVARIANT LLC · Transportation

Encourage use of commercial software to maximize infrastructure investments; support funding for the FAA's efforts related to the 5G rollout.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2023

Registrant: INVARIANT LLC · Law Enforcement/Crime/Criminal Justice

Support funding for commercial software to help HIDTAS respond to fentanyl and opioid crisis.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2025

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Highlight how Palantir's technology is being used by hospitals and health systems.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2023

Registrant: INVARIANT LLC · Health Issues

Support funding for the Food and Drug Administration 21 Forward Program, National Institutes of Health N3C Program, and Centers for Disease Control and Prevention, the Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2022

Registrant: INVARIANT LLC · Health Issues

Discuss the use of Palantir's commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support funding for the Food and Drug Administration's 21Forward Initiative; monitor Senate pandemic preparedness legislation including S.3799, PREVENT Pandemics Act; support funding for the National COVID Cohort Collaborative.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2024

Registrant: INVARIANT LLC · Taxation/Internal Revenue Code

Discuss how commercial technology can be leveraged by IRS to fight fraud and improve customer experience.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2026

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2025

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2024

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Highlight how Palantir's technology is being used by hospitals and health systems.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2022

Registrant: INVARIANT LLC · Homeland Security

Support the ongoing deployment of commercial data software solutions related to USCG and ICE-HIS; monitor S. 4802/H.R. 6865, Coast Guard Authorization Act of 2022.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2024

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Highlight how Palantir's technology is being used by hospitals and health systems.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2023

Registrant: INVARIANT LLC · Law Enforcement/Crime/Criminal Justice

Support funding for commercial software to help HIDTAS respond to fentanyl and opioid crisis.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2025

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2022

Registrant: INVARIANT LLC · Transportation

Encourage use of commercial software to maximize infrastructure investments; support funding for the FAA's efforts related to the 5G rollout.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2022

Registrant: INVARIANT LLC · Homeland Security

Support the ongoing deployment of commercial data software solutions related to USCG and ICE-HSI; monitor S.4802 / H.R.6865, Coast Guard Authorization Act of 2022.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2025

Registrant: INVARIANT LLC · Health Issues

Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Highlight how Palantir's technology is being used by hospitals and health systems.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2023

Registrant: INVARIANT LLC · Health Issues

Support funding for the Food and Drug Administration 21 Forward Program, National Institutes of Health N3C Program, and Centers for Disease Control and Prevention Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant networks IT and software infrastructure.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2022

Registrant: INVARIANT LLC · Health Issues

Discuss the use of Palantir's commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support funding for the Food and Drug Administration's 21Forward Initiative; monitor Senate pandemic preparedness legislation including S. 3799, PREVENT Pandemics Act; support funding for the National COVID Cohort Collaborative.

LDA filing ↗
PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2025

Registrant: INVARIANT LLC · Taxation/Internal Revenue Code

Discuss how commercial technology can be leveraged by IRS to fight fraud and improve customer experience.

LDA filing ↗